---
title: Phenotypes and treatment outcomes in idiopathic pulmonary arterial hypertension
  patients with comorbidities
date: '2024-01-30'
linkTitle: https://pubmed.ncbi.nlm.nih.gov/38288083/?utm_source=curl&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&fc=20220326224207&ff=20240130170654&v=2.18.0
source: heidelberg[Affiliation]
description: Idiopathic pulmonary arterial hypertension (IPAH) is often diagnosed
  in elderly patients with many comorbidities. Whereas a clear treatment strategy
  and risk assessment is recommended for patients with rare classical IPAH, monotherapy
  with phosphodiesterase type 5 inhibitors or endothelin receptor antagonists followed
  by regular follow-up and individualised therapy should be used for patients with
  many cardiopulmonary comorbidities. Here, we focus on these patients with IPAH and
  ...
disable_comments: true
---
Idiopathic pulmonary arterial hypertension (IPAH) is often diagnosed in elderly patients with many comorbidities. Whereas a clear treatment strategy and risk assessment is recommended for patients with rare classical IPAH, monotherapy with phosphodiesterase type 5 inhibitors or endothelin receptor antagonists followed by regular follow-up and individualised therapy should be used for patients with many cardiopulmonary comorbidities. Here, we focus on these patients with IPAH and ...